0001646343-18-000004.txt : 20180515
0001646343-18-000004.hdr.sgml : 20180515
20180515161742
ACCESSION NUMBER: 0001646343-18-000004
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180331
FILED AS OF DATE: 20180515
DATE AS OF CHANGE: 20180515
EFFECTIVENESS DATE: 20180515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP
CENTRAL INDEX KEY: 0001646343
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17280
FILM NUMBER: 18836743
BUSINESS ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 1100
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 213-7033
MAIL ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 1100
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001646343
XXXXXXXX
03-31-2018
03-31-2018
NEXTHERA CAPITAL LP
900 THIRD AVENUE
SUITE 1100
NEW YORK
NY
10022
13F HOLDINGS REPORT
028-17280
N
Daniel Malek
Managing Member of the General Partner
6462137030
Daniel Malek
New York
NY
05-15-2018
0
40
607263
false
INFORMATION TABLE
2
nexthera13f_q12018.xml
Abeona Therapeutics Inc
COM
00289Y107
5302
369500
SH
SOLE
369500
0
0
Adverum Biotechnologies Inc
COM
00773U108
2907
501183
SH
SOLE
501183
0
0
Allergan PLC
SHS
G0177J108
41840
248620
SH
SOLE
248620
0
0
Akorn Inc
COM
009728106
9439
504503
SH
SOLE
504503
0
0
Arrowhead Pharmaceuticals Inc
COM
04280A100
8033
1114097
SH
SOLE
1114097
0
0
AstraZeneca PLC
SPONSORED ADR
046353108
16925
484000
SH
SOLE
484000
0
0
BioMarin Pharmaceutical Inc
COM
09061G101
21016
259235
SH
SOLE
259235
0
0
BioMarin Pharmaceutical Inc
COM
09061G101
8731
107700
SH
Call
SOLE
107700
0
0
Bristol-Myers Squibb Co
COM
110122108
21657
342399
SH
SOLE
342399
0
0
Cara Therapeutics Inc
COM
140755109
4346
351050
SH
SOLE
351050
0
0
Cymabay Therapeutics Inc
COM
23257D103
11076
852686
SH
SOLE
852686
0
0
Catalyst Biosciences Inc
COM NEW
14888D208
13896
538624
SH
SOLE
538624
0
0
Cellectis SA
SPONSORED ADS
15117K103
10485
332754
SH
SOLE
332754
0
0
Clovis Oncology Inc
COM
189464100
12809
242600
SH
Call
SOLE
242600
0
0
Corcept Therapeutics Inc
COM
218352102
17193
1045196
SH
SOLE
1045196
0
0
Dova Pharmaceuticals Inc
COM
25985T102
15411
568243
SH
SOLE
568243
0
0
FibroGen Inc
COM
31572Q808
6971
150888
SH
SOLE
150888
0
0
Homology Medicines Inc
COM
438083107
243
13000
SH
SOLE
13000
0
0
Global Blood Therapeutics Inc
COM
37890U108
15222
315147
SH
SOLE
315147
0
0
Heron Therapeutics Inc
COM
427746102
11288
409000
SH
SOLE
409000
0
0
Immunomedics Inc
COM
452907108
15799
1081410
SH
SOLE
1081410
0
0
Insmed Inc
COM PAR $.01
457669307
20685
918523
SH
SOLE
918523
0
0
Kura Oncology Inc
COM
50127T109
6599
351955
SH
SOLE
351955
0
0
Madrigal Pharmaceuticals Inc
COM
558868105
4231
36226
SH
SOLE
36226
0
0
Menlo Therapeutics Inc
COM
586858102
2786
74142
SH
SOLE
74142
0
0
Mylan NV
SHS EURO
N59465109
10745
261000
SH
SOLE
261000
0
0
NewLink Genetics Corp
COM
651511107
3625
500000
SH
Call
SOLE
500000
0
0
OncoSec Medical Inc
COM NEW
68234L207
3881
2064297
SH
SOLE
2064297
0
0
Pacira Pharmaceuticals Inc/DE
COM
695127100
14909
478620
SH
SOLE
478620
0
0
Perrigo Co PLC
SHS
G97822103
4646
55748
SH
SOLE
55748
0
0
Sage Therapeutics Inc
COM
78667J108
12600
78227
SH
SOLE
78227
0
0
Seattle Genetics Inc
COM
812578102
18998
362974
SH
SOLE
362974
0
0
Sangamo Therapeutics Inc
COM
800677106
14941
786376
SH
SOLE
786376
0
0
Shire PLC
SPONSORED ADR
82481R106
20846
139543
SH
SOLE
139543
0
0
Sol-Gel Technologies Ltd
SHS
M8694L103
5334
517873
SH
SOLE
517873
0
0
Stemline Therapeutics Inc
COM
85858C107
8011
523624
SH
SOLE
523624
0
0
SPDR S&P Biotech ETF
S&P BIOTECH
78464A870
175460
2000000
SH
Put
SOLE
1000000
0
0
Xenon Pharmaceuticals Inc
COM
98420N105
1857
379071
SH
SOLE
379071
0
0
Zafgen Inc
COM
98885E103
2992
401558
SH
SOLE
401558
0
0
Zosano Pharma Corp
COM NEW
98979H202
3528
700000
SH
SOLE
700000
0
0